Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial

BACKGROUND: Uncontrolled bleeding after cardiac surgery can be life-threatening. Factor eight inhibitor bypassing activity (FEIBA) is a prothrombin complex concentrate empirically used as rescue therapy for correction of refractory bleeding diathesis post-cardiopulmonary bypass (CPB). FEIBA used as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sera, Valerie A., Stevens, Ann E., Song, Howard K., Rodriguez, Victor M., Tibayan, Frederick A., Treggiari, Miriam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252226/
https://www.ncbi.nlm.nih.gov/pubmed/34215339
http://dx.doi.org/10.1186/s40814-021-00873-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252226/
https://www.ncbi.nlm.nih.gov/pubmed/34215339
http://dx.doi.org/10.1186/s40814-021-00873-5

Ejemplares similares